DalsnaFinance Account

First Tracks Biotherapeutics Inc $TRAX

Health Care

Russell 2000 California

Create a scorecard

$43.14

+0.37 (+0.87%)

As of Oct 22, 2026, 9:31 PM EDT

Price history

Loading chart…

First Tracks Biotherapeutics Inc (TRAX) is trading up at $43.14 (+0.87%), as of the latest quote. It is a Russell 2000 constituent in the Health Care sector.

First Tracks Biotherapeutics Inc net income history

Net income

First Tracks Biotherapeutics Inc quarterly financial statements
	Q1 FY25Mar 2025	Q2 FY25Jun 2025	Q1 FY26Mar 2026	Q2 FY26Jun 2026
Income statement
Operating income	−$51.3M	−$45.9M	−$52.8M	−$34.9M
Net income	−$47.2M	−$42.4M	−$50.5M	−$33.4M
EPS (diluted)	−$1.55	−$1.47	−$1.45	−$0.95
Balance sheet
Cash and equivalents	$98.6M	$44.3M	$248.5M	$168.0M
Total assets	—	—	$290.6M	$183.1M
Total liabilities	—	—	$33.1M	$14.3M
Shareholders' equity	$357.7M	$270.7M	$257.5M	$168.8M
Cash flow
Operating cash flow	−$45.0M	−$38.6M	−$32.6M	−$31.9M
Capital expenditure	$35.0K	$39.0K	$17.0K	$25.0K
Free cash flow	−$45.0M	−$38.7M	−$32.6M	−$31.9M

From First Tracks Biotherapeutics Inc's 10-Q filings with the SEC. Each period shows the latest figure the company has reported for it, including restatements. Filings on SEC EDGAR →